FDA Brief

Warning letters Drugs

FDA warning letter to

Viatris, Inc.

Issued Dec 19, 2024Posted Dec 24, 2024Center for Drug Evaluation and Research (CDER)

CGMP/Finished Pharmaceuticals/Adulterated. We haven't summarized this letter yet. Read it on fda.gov.

Viatris, Inc.'s FDA history

Recalls in the last 12 months

Oct 28 Class III Viatris, Inc.
Drug
Telmisartan and Amlodipine, Tablets, USP, 40mg/5 mg, 30-count Bottle, Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 USA, Made in India, NDC 0378-1075-93.
Superpotent Drug: potential for the Telmisartan content in these lots to exceed specifications
Apr 15 Class II Viatris, Inc.
Drug
Xanax XR, alprazolam, extended-release tablets, 3 mg, 60 Tablets bottles, Rx only, Distributed by: Viatris Specialty LLC, Morgantown, WV 06506, U.S.A, Made in Ireland, NDC 58151-506-91
Failed Dissolution Specifications

Full company page